Abstract
Cladosporium trichoides and Sporothrix schenckii are fungi known to be pathogenic for man. No effective chemotherapy is available for cladosporiosis, and systemic sporotrichosis can be very resistant to antifungal chemotherapy. Experimental infections of mice with these fungi resembled their respective infections in man and provided a model for evaluating a new antifungal agent, 5-fluorocytosine (5-FC). Our results with four isolates of C. trichoides demonstrated a statistically significant dose-related therapeutic effect with 5-FC. Mortality was significantly reduced in all treatment groups, and survivors showed no clinical sign of disease despite positive brain cultures. Results with a single isolate of S. schenckii were less encouraging. Fatality rate was significantly decreased in all treatment groups, but no trend was noted with increasing 5-FC dosage. Survivors manifested the signs of active disease, and all liver and spleen cultures were positive for S. schenckii. These results indicated that (i) 5-FC may be the first drug useful in the treatment of cladosporiosis, and (ii) 5-FC may have only limited therapeutic benefit in systemic sporotrichosis.
Full text
PDF



Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BINFORD C. H., THOMPSON R. K., GORHAM M. E. Mycotic brain abscess due to Cladosporium trichoides, a new species; report of a case. Am J Clin Pathol. 1952 Jun;22(6):535–542. doi: 10.1093/ajcp/22.6.535. [DOI] [PubMed] [Google Scholar]
- Block E. R., Bennett J. E. Pharmacological studies with 5-fluorocytosine. Antimicrob Agents Chemother. 1972 Jun;1(6):476–482. doi: 10.1128/aac.1.6.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- González Ochoa A. Curación de la criptococosis y de la cromomicosis con 5-fluorocitosina. Rev Invest Salud Publica. 1970 Jan-Mar;30(1):63–76. [PubMed] [Google Scholar]
- Itani Z. Die Chromomykose. Viszeral-metastasierender Typ. Dtsch Med Wochenschr. 1970 May 15;95(20):1100–1106. doi: 10.1055/s-0028-1108594. [DOI] [PubMed] [Google Scholar]
- KING A. B., COLLETTE T. S. Brain abscess due to Cladosporium trichoides; report of the second case due to this organism. Bull Johns Hopkins Hosp. 1952 Oct;91(4):298–305. [PubMed] [Google Scholar]
- Lopes C. F., Alvarenga R. J., Cisalpino E. O., Martinelli B., Santos P. U., Armond S. Tratamento da cromomicose pela 5-fluorocitosina. Primeiros resultados. Hospital (Rio J) 1969 Apr;75(4):1335–1342. [PubMed] [Google Scholar]
- Musella R. A., Collins G. H. Cerebral chromoblastomycosis. Case report. J Neurosurg. 1971 Aug;35(2):219–222. doi: 10.3171/jns.1971.35.2.0219. [DOI] [PubMed] [Google Scholar]
- SEGRETAIN G., MARIAT F., DROUHET E. Sur Cladosporium trichoides isolé d'une mycose cérébrale. Ann Inst Pasteur (Paris) 1955 Oct;89(4):465–470. [PubMed] [Google Scholar]
- Steer P. L., Marks M. I., Klite P. D., Eickhoff T. C. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med. 1972 Jan;76(1):15–22. doi: 10.7326/0003-4819-76-1-15. [DOI] [PubMed] [Google Scholar]
- TSUBURA E., SCHWARZ J. Treatment of experimental sporotrichosis in mice with griseofulvin and amphotericin B. Antibiot Chemother (Northfield) 1960 Dec;10:753–757. [PubMed] [Google Scholar]
- Wilson D. E., Mann J. J., Bennett J. E., Utz J. P. Clinical features of extracutaneous sporotrichosis. Medicine (Baltimore) 1967 May;46(3):265–279. doi: 10.1097/00005792-196705000-00002. [DOI] [PubMed] [Google Scholar]
- Winter T. Q., Pearson K. D. Systemic sporothrixosis. Radiology. 1972 Sep;104(3):579–583. doi: 10.1148/104.3.579. [DOI] [PubMed] [Google Scholar]


